Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
- 31 March 2003
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 110 (3) , 609-614
- https://doi.org/10.1016/s0161-6420(02)01891-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOPOphthalmology, 2001
- Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertensionAdvances in Therapy, 2001
- The Pharmacology of Bimatoprost (Lumigan™)Survey of Ophthalmology, 2001
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001
- Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoidsSurvey of Ophthalmology, 1997
- A Six-month, Randomized, Double-masked Study Comparing Latanoprost with Timolol in Open-angle Glaucoma and Ocular HypertensionOphthalmology, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Effects on Intraocular Pressure and Side Effects of 0.005% Latanoprost Applied Once Daily, Evening or MorningOphthalmology, 1995
- The Effects on Aqueous Dynamics of PhXA41, a New Prostaglandin F2α Analogue, After Topical Application in Normal and Ocular Hypertensive Human EyesArchives of Ophthalmology (1950), 1993
- Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human EyesOphthalmology, 1993